Imperial College London

DrSanjayPopat

Faculty of MedicineNational Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Begum:2022,
author = {Begum, P and O'Sullvan, H and D'Arienzo, P and Cunningham, N and Vick, J and Bhosle, J and Davidson, M and Minchom, A and O'Brien, M and Yousaf, N and Cui, W and Popat, S},
pages = {S461--S462},
publisher = {ELSEVIER SCIENCE INC},
title = {Lorlatinib Treatment Related Adverse Events: Single Centre Real-World Experience in ALK and ROS1-driven NSCLC},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000858678101253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Begum,P
AU - O'Sullvan,H
AU - D'Arienzo,P
AU - Cunningham,N
AU - Vick,J
AU - Bhosle,J
AU - Davidson,M
AU - Minchom,A
AU - O'Brien,M
AU - Yousaf,N
AU - Cui,W
AU - Popat,S
EP - 462
PB - ELSEVIER SCIENCE INC
PY - 2022///
SN - 1556-0864
SP - 461
TI - Lorlatinib Treatment Related Adverse Events: Single Centre Real-World Experience in ALK and ROS1-driven NSCLC
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000858678101253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -